Ratio Therapeutics, Inc. — SEC Form D Filing
Ratio Therapeutics, Inc. filed an SEC Form D on July 31, 2026, reporting $70.00M raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 31, 2026
- Amount reported
- $70.00M
- Round stage
- Series B+
- Industry
- Pharmaceuticals
- Website
- https://ratiotherapeutics.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Drug development for complex diseases often suffers from a lack of precise and quantifiable data to optimize therapeutic ratios and efficacy.
Solution
Ratio Therapeutics, Inc. provides advanced analytical platforms and services to pharmaceutical companies, enabling them to precisely measure and optimize the therapeutic ratios of their drug candidates for improved patient outcomes.
Why now
The specific timing catalyst for Ratio Therapeutics is unclear from available information.
Source: SEC EDGAR Form D filing